Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2019 | 03-2018 | 03-2007 | 03-2006 | |
| Operating Expenses | 28,425 | 0 | 0 | 0 |
| Operating Income | -28,425 | N/A | N/A | N/A |
| Other Income | -155 | 0 | 0 | 0 |
| Pre-tax Income | -28,580 | 0 | 0 | 0 |
| Income Tax | 19 | N/A | N/A | N/A |
| Net Income Continuous | -28,599 | N/A | N/A | N/A |
| Net Income | $-28,599 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -1.29 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.29 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.29 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.29 | N/A | N/A | N/A |
| EBITDA(a) | $-28,415 | $N/A | $N/A | $N/A |